These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18154280)

  • 1. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
    Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO
    J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
    Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
    J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
    Ko S; Lee W; Lee S; Park H
    J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new on CDC25 phosphatase inhibitors.
    Contour-Galcera MO; Sidhu A; Prévost G; Bigg D; Ducommun B
    Pharmacol Ther; 2007 Jul; 115(1):1-12. PubMed ID: 17531323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
    Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
    J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdc25 phosphatases: structure, specificity, and mechanism.
    Rudolph J
    Biochemistry; 2007 Mar; 46(12):3595-604. PubMed ID: 17328562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the CDC25 phosphatases.
    Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
    Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexibility and inhibitor binding in cdc25 phosphatases.
    Arantes GM
    Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
    Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
    Wang JG; Xiao YJ; Li YH; Ma Y; Li ZM
    Bioorg Med Chem; 2007 Jan; 15(1):374-80. PubMed ID: 17049866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the virtual screening of Cdc25A phosphatase inhibitors with the homology modeled protein structure.
    Park H; Jeon YH
    J Mol Model; 2008 Sep; 14(9):833-41. PubMed ID: 18504625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
    Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
    J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.